Prospects for Gene-Based Immunopharmacology in Salivary Glands

Yamano Seiichi, J. Baum Bruce

doi:10.1254/jjp.82.281

Prospects for Gene-Based Immunopharmacology in Salivary Glands

DOI Web Site Web Site Web Site Web Site PubMed ほか1件をすべて表示一部だけ表示参考文献79件

Yamano Seiichi

Gene Therapy and Therapeutics Branch,National Institute of Dental and Craniofacial Research,National Institutes of Health,Bethesda,Maryland 20892,USA
J. Baum Bruce

Gene Therapy and Therapeutics Branch,National Institute of Dental and Craniofacial Research,National Institutes of Health,Bethesda,Maryland 20892,USA

書誌事項

タイトル別名

Current Perspective. Prospects for Gene-Based Immunopharmacology in Salivary Glands.

この論文をさがす

説明

The clinical potential of gene transfer is increasing.One likely major application of this emerging biotechnology will be for gene therapeutics, the use of a gene as a drug.Salivary glands provide an unusual but increasingly valuable target site for gene transfer.Studies in animal salivary glands from several laboratories, including our own, have provided proof of this concept.In this review, we provide a background and perspective on possible strategies for gene-based immunopharmacology in salivary glands.We use as a target disease model the autoimmune exocrinopathy Sjögren’s syndrome.